Abstract
Azathioprine (“Imuran”) is an S-substituted 6-mercaptopurine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Alexandre, G.P.J., Murray, J.E., Dammin, G.J, Nolan, B.: Immunosuppressive drug therapy in canine renal and skin homografts. Transplantation 1, 432–461 (1963).
Arinovtche, R., Loewi, G.: Comparison of the effects of two cytotoxic drugs and of anti- lymphocytic serum, on immune and non-immune inflammation in experimental animals. Ann. rheum. Dis. 29, 32–39 (1970).
Aronsen, K.F., Husberg, B., Pihl, B.: Immunosuppressive treatment in non-transplanted dogs. Azathioprine versus azathioprine-antilymphocyteimmunoglobulin-G. Acta chir. scand. 135, 475–481 (1969).
Babington, R. G., Wedeking, P.W.: The influence of cinanserin and selected pharmacologic agents on experimental allergic encephalomyelitis (EAE). J. Pharmacol, exp. Ther. 177, 454–460 (1971).
Bach, J.F.: Immunosuppression by chemical agents. Transplant. Proc. 3, 27–33 (1971).
Bach, J. F.: Antigen-binding cells. In: Cell-mediated immunity. In vitro correlates, pp. 51–74. Basel: Karger 1971a.
Bach, J. F., Dardenne, M.: Études sur le métabolisme de L’azathioprine. C.R. Acad. Sci. (Paris) 271, 453–456 (1970).
Bach, J.F., Dardenne, M.: The metabolism of azathioprine in renal failurè. Transplantation 12, 253–259 (1971).
Bach, J.F., Dardenne, M.: Activities of immunosuppressive agents In vitro. I. Rosette inhibition by azathioprine. Rev. Europ. études clin, etbiol. 16, 770–777 (1971a).
Bach, J.F., Dardenne, M.: Serum immunosuppressive activity of azathioprine in normal subjects and patients with liver diseases. Proc. roy. Soc. Med. 65, 260–263 (1972).
Bach, J.F., Dardenne, M.: Antigen recognition by T lymphocytes. II. Similar effects of azathioprine, antilymphocyte serum and anti-theta serum on rosette-forming lymphocytes in normal and neonatally thymectomized mice. Cell. Immunol. 3, 11–21 (1972a).
Bach, J.F., Dardenne, M., Crosnier, J.: Bone marrow-reactivity to azathioprine due to metabolism abnormality. Ann. intern. Med.
Baöh, J.F., Dardenne, M., Davies, A. J.S.: Early effect of adult thymectomy. Nature (Lond.) 231, 110–111 (1971a).
Bach, J. F., Dardenne, M., Fournier, C.: In vitro evaluation of immunosuppressive drugs. Nature (Lond.) 222, 998–999 (1969).
Bach, J.F., Dardenne, M., Goldstein, A.L., Guha, A., White, A.: Appearance of T-cell markers in bone marrow rosette-forming cells after incubation with thymosin, a thymic hormone. Proc. nat. Acad. Sci. (Wash.) 68, 2734–2738 (1971).
Bach, M.A., Bach, J.F.: Activities of immunosuppressive agents In vitro. II. Different timing of azathioprine and methotrexate in inhibition and stimulation of mixed lymphocyte reaction. Clin. exp. Immunol. 11, 89–98 (1972).
Berenbaum, M.C.: IS azathioprine a better immunosuppressive than 6-mercaptopurine ? Clin, exp. Immunol. 8, 1–8 (1971).
Blancuzzi, V., Elion, G. B.: Unpublished.
Bloom, B.R., Jimenez, L., MARCUS, P.I.: A plaque assay for enumerating antigen-sensitive cells in delayed-type hypersensitivity. J. exp. Med. 132, 16–30 (1970).
Board, J. A., Lee, H.M., Draper, D. A., Hume, D.M.: Pregnancy following kidney homotrans- plantation from a non-twin: Report of a case with concurrent administration of azathioprine and prednisone. Obstet. Gynec. 29, 318–323 (1967).
Boll, I., Klimas, J., Willigerodt, B.: Die Wirkung von 6-Mercaptopurin und Azathioprin auf menschliches Knochenmark In vitro. Arzneimittel-Forsch. 21, 502–504 (1971).
Borel, Y., Fauconnet, M., Miescher, P.A.: Effect of 6-mercaptopurine (6-MP) on different classes of antibody. J. exp. Med. 122, 263–275 (1965).
Borel, Y., Schwartz, R. S.: Inhibition of immediate and delayed hypersensitivity in the rabbit by 6-mercaptopurine. J. Immunol. 92, 754–761 (1964).
Bresnick, E.: The metabolism In vitro of antitumor imidazolyl derivatives of mercaptopurines. Fed. Proc. 18, 371 (1959).
Brooke, M.S.: Immunological paralysis in mice exposed to sublethal irradiation or treated with 6-mercaptopurine. Transplantation 4, 1–7 (1966).
Calne, R.Y.: Renal transplantation, 2nd Ed. London: Edward Arnold, Ltd. 1967.
Calne, R. Y., Alexandre, G.P.J., Murray, J.E.: A study of the effects of drugs in prolonging survival of homologous renal transplants in dogs. Ann. N. Y. Acad. Sci. 99, 743–761 (1962).
Caplan, R.M., Dossetor, J.B., Matjghan, G.B.: Pregnancy following cadaver kidney transplantation. Amer. J. Obstet. Gynec. 106, 644–648 (1970).
Casey, T.P.: The development of lymphomas in mice with autoimmune disorders treated with azathioprine. Blood 31, 396–399 (1968a).
Casey, T. P.: Azathioprine (Imuran) administration and development of malignant lymphomas in NZB mice. Clin. exp. Immunol. 3, 305–312 (1968b).
Chalmers, A. H., Knight, P. R., Atkinson, M.R.: Conversion of azathioprine into mercapto- purine and mercaptoimidazole derivatives In vitro and during immunosuppressive therapy. Aust. J. exp. Biol. med. Sci. 45, 681–691 (1967).
Chalmers, A. H., Knight, P. R., Atkinson, M.R.: 6-Thiopurines as substrates and inhibitors of purine oxidases: a pathway for conversion of azathioprine into 6-thiouric acid without release of 6-mercaptopurine. Aust. J. exp. Biol. med. Sci. 47, 263–273 (1969).
Chan, G. Y., Stone, R.L.: Inhibition of nucleic acid and protein synthesis in mouse spleen cells In vitro by azathioprine. Appl. Microbiol. 20, 910–912 (1970).
Connon, A.F.: Effects of azathioprine on reproduction in rats. J. Reprod. Fértil. 18, 165–166 (1969).
Dalldorf, G., Carvalho, R.P.S., Jamara, M., Frost, P., Ehrlich, D., Marigo, C.: The lymphomas of Brazilian children. J. Amer. med. Ass. 208, 1365–1368 (1969).
Demiranda, P., Beacham, L.M., Ill, Creagh, T., Elion, G.B.: Metabolic fate of the imidazole moiety of azathioprine (Imuran). Abstract, Fifth International Congress on Pharmacology 55 (1972).
Demiranda, P., Cinx, L. C.: Reaction of azathioprine (Imuran) with 14c-glycine in the rat. Fed. Proc. 29, 608 (1970).
Denman, E.J., Denman, A.M., Greenwood, B.M., Gall, D., Heath, R.B.: Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann. rheum. Dis. 29, 220–231 (1970).
Dutton, R. W., Pearce, J.D.: A survey of the effect of metabolic antagonists on the synthesis of antibody in an in vitro system. Immunology 5, 414–423 (1962).
Eberle, P., Htxnstein, W., Perings, E.: Chromosomes in patients treated with Imuran. Hum. Genet. 6, 69–73 (1968).
Egger, G., Ackman, D.).: Light microscopic examination of the jejunum after long-standing azathioprine treatment. Experientia (Basel) 27, 326 (1971).
Elion, G. B.: Unpublished.
Elion, G.B.: Biochemistry and pharmacology of purine analogues. Fed. Proc. 26, 898–904 (1967).
Elion, G.B.: Discussion. In: Miescher, P.A., Grabor, P. (Eds.): International symposium on immunopathology, Fifth, Italy, June 1967, pp. 399–401. New York: Grune and Stratton 1968.
Elion, G.B.: The comparative metabolism of “Imuran” and 6-mercaptopurine (6-MP) in man. Proc. Amer. Ass. Cancer Res. 10, 21 (1969).
Elion, G.B.: The significance of azathioprine metabolites. Proc. roy. Soc. Med. 65, 257–260 (1972).
Elion, G. B., Benezra, F. M., Carrington, L. O., Strelitz, R. A.: Metabolic fate of 14C-azathio- prine. Fed. Proc. 29, 607 (1970).
Elion, G.B., Callahan, S.W., Bieber, S., Hitchings, G.H., Rundles, R.W.: A summary of investigations with 6-[(r-methyl-4’nitro-5’-imidazolyl)] thiopurine. Cancer Chemother. Rep. 14, 93–98 (1961).
Elion, G.B., Callahan, S.W., Hitchings, G.H., Ründles, R.W., Laszlo, J.: Experimental, clinical and metabolic studies of thiopurines. Cancer Chemother. Rep. 16, 197–202 (1962).
Elion, G. B., Callahan, S. W., Rtjndles, R. W., Hitchings, G. H.: Relationship between metabolic fates and antitumor activities of thiopurines. Cancer Res. 23, 1207–1217 (1963).
Elion, G. B., Hitchings, G. H.: Metabolic basis for the actions of analogs of purines and pyrim- idines. In: Advances in chemotherapy, Vol. 2, pp. 91–177. New York: Academic Press 1965.
Eltringham, J.R.: Effect of azathioprine and amethopterin on secondary disease in the rhesus monkey. Exp. Hematol. 10, 12–13 (1966).
Floersheim, G. L., Seiler, K.: Differential effects of immunosuppressive drugs on a cutaneous graft-versus-host reaction in chickens. Transplantation 5, 1355–1370 (1967).
Folb, R.I., Trounce, J. R.: Immunological aspects of candida infection complicating steroid and immunosuppressive drug therapy. Lancet II, 1112–1114 (1970).
Fofrnier, C., Bach, M. A., Dardenne, M., Bach, J.F.: Selective action of azathioprine on T cells. Transplant. Proc. 5, 523–526 (1973).
Frankel, H.H., Yamamoto, R.S., Weisburgeb, E-K., Weisbubger, J.H.: Chronic toxicity of azathioprine and the effect of this immunosuppressant on liver tumor induction by the carcinogen N-hydroxy-N-2-fluorenylacetamide. Toxicol, appl. Pharmacol. 17, 462–480 (1970).
Friedrich, U., Zeuthen, E.: Chromosomenabnormitäten und Behandlung mit Imuran (Azathioprin) nach Nierentransplantationen. Hum. Genet. 8, 289–294 (1970).
Gabor, E.P., Scott, J.L.: Effect of thiopurines on rat lymphoid tissues. Clin. Res. 16, 154 (1968).
Gelfand, M.C., Nowakowski, A., Friedman, E.A., Knepshield, J.H.: Synergism in immunosuppression. III. Allograft rejection and humoral antibody production in intact and splenectomized mice. Transplantation 12, 377–383 (1971).
Gillibrand, P.N.: Systemic lupus erythematosus in pregnancy treated with azathioprine. Proc. roy. Soc. Med. 59, 834 (1966).
Githens, J.H., Rosenkrantz, J. G., Tunnock, S.M.: Teratogenic effects of azathioprine (Imuran). J. Pediat. 66, 959–961 (1965).
Glasgow, L.A.: Immunosuppression, interferon, and viral infections. Fed. Proc. 30, 1846– 1851 (1971).
Gleichmann, E., Gleichmann, H., Schwabtz, R.S.: Immunologic induction of malignant lymphoma: genetic factors in the graft-versus-host model. J. nat. Cancer Inst. 49, 793–801 (1972).
Gonzalez, E.M., Kbejczy, K., Malt, R.A.: Modification of nucleic acid synthesis in regenerating liver by azathioprine. Surgery 68, 254–259 (1970).
Gotjamanos, T.: The effect of azathioprine on phagocytic activity and morphology of reticuloendothelial organs in mice. Pathology 3, 171–179 (1971).
Hambubgeb, J., Cbosnieb, J., Dobmont, J., Bach, J.F.: Renal transplantation. Theory and practice. Baltimore: Williams and Wilkins 1972.
Hampel, K.E., Lackneb, A., Schulz, G., Busse, V.: Chromosomal mutations by azathioprine in human leukocytes In vitro. Z. Gastroent. 9, 47–51 (1971).
Haxhe, J. J., Alexandbe, G.P. J., Kestens, P. J.: The effect of Imuran and azaserine on liver function tests in the dog. Its relation to the detection of graft rejection following liver transplantation. Arch. int. Pharmacodyn. 168, 366–372 (1967).
Heine, K.M., Stobbe, H., Klatt, R., Apostoloff, E., Dutz, W.: Lymphocyte transformation tests in patients under treatment with immunosuppressive drugs. Helv. med. Acta 35, 140–145 (1969/70).
Hebsh, E.M., Oppenheim, J.J.: Inhibition of In vitro lymphocyte transformation during chemotherapy in man. Cancer Res. 27, 98–105 (1967).
Hill, R.H., JB., Rowlands, D.T., JB., Rifkind, D.: Infectious pulmonary disease in patients receiving immunosuppressive therapy for organ transplantation. New Engl. J. Med. 271, 1021–1027 (1964).
Hibsch, M.S., Black, P.H., Tbacy, G.S., Leibowitz, S., Schwabtz, R.S.: Leukemia virus activation in chronic allogeneic disease. Proc. nat. Acad. Sci. (Wash.) 67, 1914–1917(1970).
Hibsch, M.S., Phillips, S.M., Solnik, C., Black, P.H., Schwabtz, R.S., Cakpenteb, C.B.: Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions In vitro. Proc. nat. Acad. Sci. (Wash.) 69, 1069–1072 (1972).
Hitchings, G. H.: Summary of informal discussion on the role of purine antagonists. Cancer Res. 23, 1218–1225 (1963).
Hitchings, G.H., Elion, G.B.: Chemical suppression of the immune response. Pharmacol. Rev. 15, 365–405 (1963).
Hitchings, G.H., Elion, G.B.: Purine analogues. In: Hochsteb, R.M., Quastel, J.H. (Eds.): Metabolic inhibitors, Vol. 1, pp. 215–237. New York: Academic Press 1963a.
Hitchings, G. H., Elion, G. B.: Thiopurines as inhibitors of the immune response. In: Shugab, D. (Ed.): FEBS Symposium, Biochemical aspects of antimetabolites and of drug hydroxylation, Vol. 16, pp. 1–10. London and New York: Academic Press 1969.
Hitchings, G.H., Elion, G.B.: The role of antimetabolites in immunosuppression and transplantation. Accounts chem. Res. 2, 202–209 (1969a).
Hitchings, G.H., Elion, G.B.: Mechanisms of action of purine and pyrimidine analogues. In: Brodsky, I., Kahn, S.B., Moyeb, J.H. (Eds.): Cancer chemotherapy II, 22nd Hahnemann Symposium, pp. 23–32. New York: Grune and Stratton 1972.
Howard, J. G.: Cellular events in the induction and loss of tolerance to pneumococcal polysaccharides. Transplant. Rev. 8, 50–75 (1972).
Hunstein, W., Pebings, E., Klose, U.: Long-term animal experiments with azathioprine (Imuran) to test its myelotoxic effect. Vehr, dtsch. Ges. inn. Med. 73, 450–453 (1967).
Huseb, H. J., Mtjbphy, G.P.: The renal and hematologic effects of immunosuppression in the rhesus monkey. Survival of autotransplants following azathioprine. Amer. Surg. 32, 243– 248 (1966).
Jensen, M.K.: Chromosome studies in patients treated with azathioprine and amethopterin. Acta med. scand. 182, 445–455 (1967).
Kaufman, J. J., Dignam, W., Goodwin, W.E., Mabtin, D.C., Goldman, R., Maxwell, M.H.: Successful normal childbirth after kidney homotransplantation. J. Amer. med. Ass. 200, 338–341 (1967).
Kelley, W.N., Rosenbloom, F.M., Seegmiller, J.E.: The effects of azathioprine (Imuran) on purine synthesis in clinical disorders of purine metabolism. J. clin. Invest. 40, 1518– 1529 (1967).
Kennealey, G. T., Lytton, B., Ruddle, N., Mitchell, M.S.: Modification of response to histocompatibility antigens with chemotherapeutic agents. Transplantation 12, 522–523 (1971).
Klein, G.: Immunological aspects of Burkitt’s lymphoma. Advanc. Immunol. 14, 187–243 (1971).
Krueger, G. R. F., Heine, U. I.: Morphogenesis of two immunologically induced mouse lymphomas. Cancer Res. 32, 573–582 (1972).
Krueger, G. R. F., Malmgren, R. A., Berard, C. W.: Malignant lymphomas and plasmacytosis in mice under prolonged immunosuppression and persistent antigenic stimulation. Transplantation 11, 138–144 (1971).
Lauro, V., Santilligiornelli, F.E., Dominici, C., Fanelli, A., Citcchia, G.: Effetti della 6-mercaptopurina e dell’azathioprina sulla fase di annidamento dell’uovo: indagine comparativa in alcune specie di roditori. Arch. Ginec. Obstet. 74, 164–177 (1969).
Lee, A.K. Y., Mackay, I.R., Rowley, M. J., Yap, C.Y.: Measurement of antibody-producing capacity of flagellin in man. IV. Studies in autoimmune disease, allergy, and after azathioprine treatment. Clin. exp. Immunol. 9, 507–518 (1971).
Leibowitz, H.M., Elliott, J. H.: Chemotherapeutic immunosuppression of the corneal graft reaction. II. Combined systemic antimetabolite and topical corticosteroid therapy. Arch. Ophthal. 76, 338–344 (1966).
Leung, F. C., Vas, S.I.: Effects of immunosuppressive drugs on secondary antibody response In vitro. Canad. J. Microbiol. 14, 7–11 (1968).
Levy, J., Barnett, E.V., Macdonald, N.S., Klinenberg, J.R., Pearson, C.M.: The effect of azathioprine on gammaglobulin synthesis in man. J. clin. Invest. 51, 2233–2238 (1972).
Malamud, D., Gonzalez, E.M., Cmu, H., Malt, R.A.: Inhibition of cell proliferation by azathioprine. Cancer Res. 82, 1226–1229 (1972).
Mandel, M.A., Decosse, J.J.: Enhancement of tumor induction in mice by long term immunosuppression. Surg. Forum 21, 129–131 (1970).
McEwan, A., Petty, L.G.: Oncogenicity of immunosuppressive drugs. Lancet I, 326–327 (1972).
Mellohs, R. C.: Murine leukemialike virus and the immunopathological disorders of New Zealand Black mice. J. infect. Dis. 120, 480–487 (1969).
Merigan, T.C., Stevens, D. A.: Viral infections in man associated with acquired immunological deficiency states. Fed. Proc. 30, 1858–1864 (1971).
Merkatz, I.R., Schwartz, G.H., David, D.S., Stenzel, K.H., Riggio, R.R., Whitsell, J.C.: Resumption of female reproductive function following renal transplantation. J. Amer. med. Ass. 216, 1749–1754 (1971).
Merrill, J.P.: Medical management of the transplant patient. In: Rapaport, F.T., Dausset, J. (Eds.): Human transplantation, pp. 66–79. New York: Grune and Stratton 1968.
Meyer Zum Büschenfelde, K. EL, Freudenberg, J.: Tierexperimentelle Untersuchungen über die Wirkung von Azathioprin auf die Bildung zirkulierender Antikörper. Klin. Wschr. 47, 379 - 482 (1969).
Miller, J. F. A. P., Basten, A., Sprent, J., Cheers, C.: Interaction between lymphocytes in immune responses. Cell. Immunol. 2, 469–495 (1971).
Miller, J. J., Cole, L. J.: Resistance of long-lived lymphocytes and plasma cells in rat lymph nodes to treatment with prednisone, cyclophosphamide, 6-mercaptopurine, and actinomy- cin D. J. exp. Med. 126, 109–125 (1967).
Mitchell, C.G., Eddleston, A.L.W.F., Smith, M.G.M., Williams, R.: Serum immunosuppressive activity due to azathioprine and its relation to hepatic function after liver transplantation. Lancet I, 1196–1199 (1970).
Moore, H.L., JR., Kozma, C.: Unpublished.
Murray, J.E., Reid, D.E., Harrison, J.H., Merrill, J.P.: Successful pregnancies after human renal transplantation. New Engl. J. Med. 269, 341–343 (1963).
Murray, J. E., Scheil, A. G. R., Moseley, R., Knight, P. R., Mcgavic, J. D., Dammin, G. J.: Analysis of mechanism of immunosuppressive drugs in renal homotransplantation. Ann. Surg. 160, 449–473 (1964).
Nathan, H.C., Bieber, S., Elion, G.B., Hitchings, G.IL: Detection of agents which interfere with the immune response. Proc. Soc. exp. Biol. (N. Y.) 107, 796–799 (1961).
Nyhan, W.L., Sweetman, L., Carpenter, D.G., Carter, C.H., Hoefnagel, D.: Effects of azathioprine in a disorder of uric acid metabolism and cerebral function. J. Pediat. 72, 111–118 (1968).
Obe, G.: Die Wirkung von 6-Mercaptopurin und Azathioprin auf menschliche Chromosomen In vitro. Arzneimittel-Forsch. 21, 504–505 (1971).
Page, D., Posen, G., Stewart, T., Harris, J.: Immunological detection of renal allograft rejection in man. Increased deoxynucleic acid synthesis by peripheral lymphoid cells. Transplantation 12, 341–347 (1971).
Paine, K.W.E.: Personal communication.
Palmer, D.L., Rifkind, D., brown, D.W.: 181I-Labeled colloidal human serum albumin in the study of reticuloendothelial system function. III. Phagocytosis and catabolism compared in normal, leukemic, and immunosuppressed human subjects. J. infect. Dis. 123, 465–469 (1971).
Patkowski, J.: On the mode of action of some immunosuppressant drugs. J. Pharm. Pharmacol. 20, 957–959 (1968).
Penn, I., Halgrimson, C.G., Starzl, T.E.: De novo malignant tumors in organ transplant recipients. Transplant. Proc. 8, 773–778 (1971).
Penn, I., Makowski, E., Droegemtjeller, W., Halgrimson, C.G., Starzl, T.E.: Parenthood in renal homograft recipients. J. Amer. med. Ass. 216, 1755–1761 (1971a).
Perper, R.J., Alvarez, B., Colombo, C., Schroder, H.: The use of a standardized adjuvant arthritis assay to differentiate between antiinflammatory and immunosuppressive agents. Proc. Soc. exp. Biol. (N.Y.) 187, 506–512 (1971).
Powell, D.: Pregnancy in active chronic hepatitis on immunosuppressive therapy. Postgrad, med. J. 45, 292–294 (1969).
Qttadracci, L.J., Hellström, I.E., Striker, G.E., Marchioro, T.L., Hellström, K.E.: Immune mechanisms in human recipients of renal allografts. Cell. Immunol. 1, 561–566 (1970).
Quinn, R. P., Elion, G. B.: Unpublished.
Reid, R.H., Piroesky, B., Dawson, P. J.: The influence of immunosuppression on virus-induc- ed lymphatic leukemia in mice. Transplantation 13, 61–65 (1972).
Rettber, M. D.: Accentuation of carbon tetrachloride-induced cirrhosis by azathioprine in the rat. Arch. Path. 90, 567–571 (1970).
Rifkind, D.: The activation of varicella-zoster virus infections by immunosuppressive therapy. J. Lab. clin. Med. 68, 463–474 (1966).
Rifkind, D., Marchioro, T.L., Waddell, W.R., Starzl, T.E.: Infectious diseases associated with renal homotransplantation. I. Incidence, types and predisposing factors. J. Amer. med. Ass. 189, 397–407 (1964).
Rosenkrantz, J.G., Githens, J.H., Cox, S.M., Kellum, D.L.: Azathioprine (Imuran) and pregnancy. Amer. J. Obstet. Gynec. 97, 387–394 (1967).
Rosenthale, M.E., Datko, L. J., Kassarich, J., Söhneid Er, F.: Chemotherapy of experimental allergic encephalomyelitis (EAE). Arch. int. Pharmacodyn. 179, 251–275 (1969).
Rowley, M. J., Mackay, I.R., Mckenzie, I. F.C.: Antibody production in immunosuppressed recipients of renal allografts. Lancet II, 708–710 (1969).
Rtjndles, R. W., Laszlo, J., Itoga, T., Hobson, J. B., Garrison, P. E., JR.: Clinical and hematologic study of 6-[(l-methyl-4-nitro-5-imidazolyl)thio]-purine and related compounds. Cancer Chemother. Itep. 14, 99–115 (1961).
Sahiar, K., Schwartz, R.S.: Inhibition of 19 S antibody synthesis by 7 S antibodv. Science 145, 395–397 (1964).
Schwartz, G.H., Stenzel, K.H., Rubin, A. L.: Depression of lymphocyte transformation by drugs In vitro. Effects of a new immunosuppressant, Cinanserin. Transplantation 8, 704– 711 (1969).
Schwartz, R.S.: Immunoregulation, oncogenic viruses, and malignant lymphomas. Lancet I, 1266–1269 (1972).
Schwartz, R.S., Andre, J.: The chemical suppression of immunity. Mechanism of cell and tissue damage produced by immune reactions. 2nd International symposium on immunopathology 1961, pp. 385–409. Basel: Benno Schwabe & Co. 1962.
Schwartz, R.S., Beldotti, L.: The treatment of chronic murine homologous disease: a comparative study of four “immunosuppressive” agents. Transplantation 3, 79–97 (1965).
Schwartz, R.S., Dameshek, W.: Drug-induced immunological tolerance. Nature (Lond.) 183, 1682–1683 (1959).
Schwartz, R.S., Dameshek, W.: The role of antigen dosage in drug-induced immunologic tolerance. J. Immunol. 90, 703–710 (1963).
Schwartz, R.S., Eisner, A., Dameshek, W.: The effect of 6-mercaptopurine on primary and secondary immune responses. J. clin. Invest. 38, 1394–1403 (1959).
Schwartz, R. S., Stack, J., Dameshek, W.: Effect of 6-mercaptopurine on antibody production. Proc. Soc. exp. Biol. (N.Y.) 99, 164–167 (1958).
Sheehan, R., Shklar, G., Tennebattm, R.: Azathioprine effects on the development of hamster pouch carcinomas. Arch. Path. 21, 264–270 (1971).
Shipley, W.U.: Immunosuppressive agents and immune cytolysis In vitro. The effect of azathioprine, hydrocortisone, and radiation on antiserum and complement-mediated lysis of cultured mammalian cells. Transplantation 14, 392–395 (1972).
Silas, D.E., Nance, F.C.: Increased tolerance to high doses of azathioprine by germfree animals. Clin. Res. 16, 84 (1968).
Simmons, R.L., Kjellstrand, C.M., Buselmeier, T.J., Najarian, J.S.: Current practice of renal transplantation at the University of Minnesota. Minn. Med. 54, 115–120 (1971).
Skarpa, M., Udall, V.: Unpublished.
Skopinska, E., Sankowski, A., Nottza, K.: Effect of azathioprine on the development of allograft sensitivity in mice. Bull. Acad. pol. Sci. CI. 617, 85–88 (1969).
Smith, J.L., Forbes, I.J.: Use of human lymphocytes in studies of drug action. Nature (Lond.) 215, 538–539 (1967).
Smith, J.L., Forbes, I.J.: Inhibition of protein synthesis in human lymphocytes by thiopu- rines. Aust. J. exp. Biol. med. Sci. 48, 267–276 (1970).
Sorensen, L. B.: Suppression of the shunt pathway in primary gout with azathioprine. Proc. nat. Acad. Sci. (Wash.) 55, 571–575 (1966).
Spiegelberg, H.L., Miescher, P.A.: The effect of 6-mercaptopurine and aminopterin on experimental immune thyroiditis in guinea pigs. J. exp. Med. 118, 869–890 (1963).
Starzl, T.E.: Experience in renal transplantation. Philadelphia: W.B. Saunders (1964).
Starzl, T.E., Marchioro, T.L., Porter, K.A., Taylor, P.D., Faris, T.D., Hermann, T. J., Hlad, C.L., Waddell, W.R.: Factors determining short- and long-term survival after orthotopic liver homotransplantation in the dog. Surgery 58, 131–155 (1965).
Stevens, J. E., Willoughby, D.A.: The anti-inflammatory effect of some immunosuppressive agents. J. Path. 97, 367–373 (1969).
Stinson, E.B., Bieber, C.P., Griepp, R.B., Clark, D.A., Shumway, N.E., Remington, J.S.: Infectious complications after cardiac transplantation in man. Ann. intern. Med. 74, 22–36 (1971).
Storti, E., Traldi, A., Quaglino, D.: Clinical studies on the effect of Imuran and vincristine in the treatment of leukemia. Acta Genet, med. (Roma) 17, 220–231 (1968).
Sunderman, C.R., Pearson, H.A.: Growth effects of long-term antileukemic therapy. J. Pediat. 75, 1058–1062 (1969).
Swanson, M.A., Schwartz, R.S.: Immunosuppressive therapy: the relation between clinical response and immunological competence. New Eng. J. Med. 277, 163–170 (1967).
Thiersch, J.B.: Effect of 6-(l’, -methyl-4’-nitro-5’-imidazolyl)mercaptopurine and 2-amino-6- (1’-methyl-4/-nitro-5’-imidazolyl)mercaptopurine on the rat litter in utero. J. Reprod. Fertil. 4, 297–302 (1962).
Tripathy, S.P., Mackaness, G.B.: The effect of cytotoxic agents on the passive transfer of cell-mediated immunity. J. exp. Med. 130, 17–30 (1969).
Tuchmann-Duplessis, H., Mercier-Parot, L.: Production de malformations des membres chez le Lapin par administration d’un antimetabolite: l’azathioprine. C.R. Acad. Sci. (Paris) 259, 3648–3651 (1964).
Tuchmann-Dfplessis, H., Mercier-Parot, L.: Considérations sur les tests tératogènes. Différences de réaction de trois espèces animales à l’égard d’un antitumoral. C.R. Soc. Biol. (Paris) 158, 1984–1990 (1964a).
Ttjchmann-Duplessis, H., Mercier-Parot, L.: Réactions provoquées chez l’embryon par deux antimétabolites chimiquement voisins. Bull, schweiz. Akad. med. Wiss. 22, 153–165 (1966).
Udall, V.: Unpublished.
Uyeki.M., Llacer, V.: Anti-tumour agents on antibody-forming cells In vitro. Biochem. Pharmacol. 19, 2419–2424 (1970).
Van Vroonhoven, T. J., Malt, R. A.: Rebound hyperplasia of regenerating liver after cessation of azathioprine. Surg. Forum 22, 339–340 (1971).
Vas, M., Lowenstein, L.: The effect of prednisone and azathioprine in mixed leucocyte culture. In: Conference and workshop on histocompatibility testing, pp. 213–215. Baltimore: Williams and Wilkins 1965.
Vinegar, R.: Unpublished.
Vinegar, R., Schreiber, W., Hugo, R.: Inhibitory effects of immunosuppressive agents on adjuvant arthritis (AA) and delayed skin reactions (DSR). Pharmacologist 10, 184 (1968).
Vredevoe, D.L., Hayes, E.F.: Effect of antilymphocytic and antithymocytic sera on the
development of mouse lymphoma. Cancer Res. 29, 1685–1690 (1969).
Walford, R.L.: Generalizing biologic hypotheses and aging: an immunological approach. In: Krohn, P.L. (Ed.): Topics in biology of aging, pp. 163–169. New York: John Wiley and Sons 1966.
Walford, R.L.: Immunologische Aspekte des Alterns. Klin. Wschr. 47, 599–605 (1969).
Wilson, D.B.: Quantitative studies on the behavior of sensitized lymphocytes In vitro. II. Inhibitory influence of the immune suppressor, Imuran, on the destructive reaction of sensitized lymphoid cells against homologous target cells. J. exp. Med. 122, 167–172 (1965).
Worth, W.S.: Azathioprine effect on normal canine liver and kidney function. Toxicol, appl. Pharmacol. 12, 1–6 (1968).
Zweiman, B., Silberberg, D. H.: In vitro lymphocyte responsiveness of human subjects receiving azathioprine. Int. Arch. Allergy 41, 428–433 (1971).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Elion, G.B., Hitchings, G.H. (1975). Azathioprine. In: Sartorelli, A.C., Johns, D.G. (eds) Antineoplastic and Immunosuppressive Agents. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 38 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65806-8_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-65806-8_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65808-2
Online ISBN: 978-3-642-65806-8
eBook Packages: Springer Book Archive